Picture of Oncorus logo

ONCR — Oncorus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Oncorus Inc expected to post a loss of 75 cents a share - Earnings Preview

* Oncorus Inc  ONCR.OQ   ONCR.O  is expected to show no
change in
quarterly revenue when it reports  results on November 1
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Oncorus Inc is for
a loss
of 75 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Oncorus Inc
is
$6​, above​ its last closing price of $0.66. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.73       -0.72      -0.74     Missed  -2.3
 Mar. 31 2022  -0.78       -0.77      -0.69     Beat    10.4
 Dec. 31 2021              -0.69      -0.77     Missed  -11.6​
 Sep. 30 2021  -0.65       -0.64      -0.65     Missed  -2.1
 ​​Jun.        -0.57       -0.56      -0.60     Missed  -6.5
 30 2021                                                
 Mar. 31 2021  -0.53       -0.53      -0.53     Met     0.9​
 Dec. 31 2020  -0.48       -0.48      -0.56     Missed  -15.5
 Sep. 30 2020  -0.94       -0.94      -21.73    Missed  -2,211
                                                        .7
 This summary was machine generated October 28 at 14:06 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Oncorus

See all news